OMALIZUMAB IS COST-EFFECTIVE COMPARED TO STANDARD OF CARE IN UNCONTROLLED SEVERE ALLERGIC ASTHMA PATIENTS

被引：0
作者：
Kaur, H. [1 ]
Dongare, S. [1 ]
Lijie, W. [2 ]
Alvares, L. [3 ]
机构：
[1] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[2] Novartis Pharma China, Shanghai, Peoples R China
[3] Novartis Pharma AG, Basel, Switzerland
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.790
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS17
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
[21]   Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients [J].
Havlucu, Yavuz ;
Yorgancioglu, Arzu ;
Kurhan, Fikret ;
Goktalay, Tugba ;
Coskun, Aysin Sakar ;
Celik, Pinar .
EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[22]   ECONOMIC EVALUATION OF OMALIZUMAB IN PATIENTS WITH UNCONTROLLED SEVERE ALLERGIC ASTHMA FROM THE PUBLIC PAYER PERSPECTIVE IN BRAZIL [J].
Suzuki, C. ;
Pepe, C. ;
Silva, N. L. .
VALUE IN HEALTH, 2012, 15 (07) :A564-A564
[23]   0 COST-EFFECTIVENESS OF MEPOLIZUMAB VERSUS OMALIZUMAB AS AN ADJUNCT THERAPY IN PATIENTS WITH UNCONTROLLED ALLERGIC ASTHMA [J].
Korgaonkar, S. ;
Inguva, S. ;
Yang, Y. .
VALUE IN HEALTH, 2018, 21 :S235-S235
[24]   Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma [J].
Kotoulas, Serafeim Chrysovalantis ;
Tsiouprou, Ioanna ;
Fouka, Eva ;
Pataka, Athanasia ;
Papakosta, Despoina ;
Porpodis, Konstantinos .
JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02)
[25]   Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma [J].
Zafari, Zafar ;
Sadatsafavi, Mohsen ;
Marra, Carlo A. ;
Chen, Wenjia ;
FitzGerald, J. Mark .
PLOS ONE, 2016, 11 (01)
[26]   Omalizumab for Severe Asthma: Beyond Allergic Asthma [J].
Loureiro, C. C. ;
Amaral, L. ;
Ferreira, J. A. ;
Lima, R. ;
Pardal, C. ;
Fernandes, I. ;
Semedo, L. ;
Arrobas, A. .
BIOMED RESEARCH INTERNATIONAL, 2018, 2018
[27]   Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate-Severe Allergic Asthma [J].
Massanari, M. ;
Milgrom, H. ;
Pollard, S. ;
Maykut, R. J. ;
Kianifard, Farid ;
Fowler-Taylor, A. ;
Geba, G. P. ;
Zeldin, R. K. .
CLINICAL PEDIATRICS, 2009, 48 (08) :859-865
[28]   Omalizumab is effective in the long-term control of severe allergic asthma [J].
Lanier, BQ ;
Corren, J ;
Lumry, W ;
Liu, J ;
Fowler-Taylor, A ;
Gupta, N .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (02) :154-159
[29]   An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma [J].
Sullivan, S. D. ;
Turk, F. .
ALLERGY, 2008, 63 (06) :670-684
[30]   THE ROLE OF OMALIZUMAB IN SEVERE (ALLERGIC) ASTHMA [J].
Lee, Taehoon .
RESPIROLOGY, 2016, 21 :9-9
12345